Search

everythinglearnresearchcommunity

for

Search:↓

Men are more likely to have larger basal cell carcinomas and squamous cell carcinomas, while women have more superficial basal cell carcinomas and tumors on their legs and central face.

Transgender and nonbinary individuals experience hair loss, with transmen on testosterone seeing more severe hair loss, while feminizing hormones may stabilize hair loss in transwomen.

AGA risk factors include age, smoking, hypertension for men, and age, dyslipidemia for women; lifestyle changes may help prevention.

Male mice with FGF5 mutations grow longer hair than females.

The statement offers guidance for hormone therapy and surgery to help gender-incongruent adults affirm a male identity.

Gender-affirming hormone therapy in South Korea aligns with international guidelines and has specific side effects.

Women with pancreatic cancer are more likely to have certain side effects from chemotherapy than men.

Women who lost hair from childhood head radiation are more likely to face mental health issues than men.

Men and minority groups face higher risks and severe outcomes from SARS-CoV, MERS-CoV, and COVID-19.

Iron levels are linked to insulin resistance in men and postmenopausal women, but not in premenopausal women.

Feminizing hormone therapy increases hair counts and improves hair-related quality of life, while masculinizing therapy may reduce large terminal hairs.

Women's facial moisturizers cost more per ounce than men's.

Hepatitis B virus alters steroid hormones in male mice, reducing dihydrotestosterone to inhibit viral replication.

Transgender individuals may face specific skin issues during gender-affirming treatments, needing personalized care.

Gender and social factors, not just biology, affect COVID-19 death rates.

Athletic trainers should understand and support the medical needs of transgender and gender-diverse patients.

Gender affects wool traits in sheep, with males and females showing differences in skin proteins related to wool growth.

The document concludes that respectful, gender-affirming healthcare improves mental health and encourages continued medical care for transgender and non-binary individuals.

Hormone therapy greatly improves the quality of life for adults seeking gender reaffirmation, but more research is needed in India.

India is seeing more cases of gender incongruence and changes in how it's understood and managed legally and medically.

Personalized hair loss treatments are needed for transgender individuals, but more research is required.

Gender-diverse individuals face more depression and anxiety, possibly due to unique stress profiles.

Men and women in Shanghai have different scalp aging and visual attention patterns.

Female-marketed minoxidil foam is more expensive than male-marketed, but generic and bulk options can reduce this gap.

Facial hair is crucial for gender affirmation, but many face financial barriers to achieving desired results.

Gender-affirming hormone therapy and surgery affect gut bacteria differently.

Gender-diverse people face more depression and anxiety, partly due to stress and lower cortisol levels.

Oral minoxidil can effectively treat hair loss in transgender and gender-diverse individuals.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.